X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Suven Life Sciences Ltd.
BSE CODE: 530239   |   NSE CODE: SUVEN   |   ISIN CODE : INE495B01038   |   02-Apr-2026 16:00 Hrs IST
BSE NSE
Rs. 157.40
9.9 ( 6.71% )
 
Prev Close ( Rs.)
147.50
Open ( Rs.)
145.10
 
High ( Rs.)
159.50
Low ( Rs.)
140.45
 
Volume
54989
Week Avg.Volume
41880
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 157.96
10.53 ( 7.14% )
 
Prev Close ( Rs.)
147.43
Open ( Rs.)
143.43
 
High ( Rs.)
162.00
Low ( Rs.)
140.30
 
Volume
1089031
Week Avg.Volume
838894
 
52 WK High-Low Range(Rs.)
118.01
299.99
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-2.16  -0.37  -0.92  -2.49  -1.78  
   CEPS(Rs)-1.89  -0.07  -0.62  -2.02  -1.32  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)36.60  38.77  39.14  32.74  28.66  
   Tax Rate(%)0.00  11.12  0.00  0.00  19.04  
Margin Ratios          
   Core EBITDA Margin(%)-778.81  -263.87  -204.13  -308.41  -225.92  
   EBIT Margin(%)-705.13  -75.00  -145.74  -300.61  -200.64  
   Pre Tax Margin(%)-707.35  -77.06  -148.66  -306.04  -207.41  
   PAT Margin (%)-707.35  -68.49  -148.66  -306.04  -167.92  
   Cash Profit Margin (%)-619.88  -12.88  -100.33  -268.95  -135.67  
Performance Ratios          
   ROA(%)-5.67  -0.89  -2.62  -6.65  -4.47  
   ROE(%)-5.73  -0.94  -3.03  -8.62  -6.02  
   ROCE(%)-5.71  -1.03  -2.97  -8.10  -6.82  
   Asset Turnover(x)0.01  0.01  0.02  0.02  0.03  
   Sales/Fixed Asset(x)0.07  0.14  0.16  0.16  0.19  
   Working Capital/Sales(x)0.13  0.05  0.06  0.21  0.16  
Efficiency Ratios          
   Fixed Capital/Sales(x)14.38  7.10  6.33  6.35  5.34  
   Receivable days71.91  32.67  28.38  47.15  54.60  
   Inventory Days25.94  22.11  0.00  2.53  3.83  
   Payable days0  0  0  0  0  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-59.94  -1443.59  -77.81  -42.33  -49.00  
   Price/Book(x)3.10  2.57  1.24  2.83  2.46  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)368.55  172.82  65.22  113.62  63.72  
   EV/Core EBITDA(x)-59.67  -207.80  -46.02  -38.53  -37.84  
   EV/EBIT(x)-52.27  -230.41  -44.75  -37.80  -31.76  
   EV/CE(x)3.07  2.39  1.03  2.82  2.13  
   M Cap / Sales371.55  185.94  78.07  113.85  66.48  
Growth Ratio          
   Net Sales Growth(%)-43.08  -13.64  14.31  -12.12  -6.50  
   Core EBITDA Growth(%)-322.75  49.32  45.06  -53.89  -6.92  
   EBIT Growth(%)-435.13  55.55  44.58  -31.66  -6.49  
   PAT Growth(%)-487.89  60.21  44.47  -60.16  -64.56  
   EPS Growth(%)-487.94  60.21  62.98  -40.22  -64.56  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)7.52  51.70  3.40  1.57  1.83  
   Quick Ratio(x)7.49  51.55  3.40  1.57  1.83  
   Interest Cover(x)-317.75  -36.47  -49.93  -55.35  -29.65  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00